Literature DB >> 9143730

Pharmacoeconomics: state of the art in 1997.

K A Schulman1, B P Linas.   

Abstract

Economic evaluation of pharmaceutical products, or pharmacoeconomics, is a rapidly growing area of research. Pharmacoeconomic evaluation is important in helping clinicians and managers make choices about new pharmaceutical products and in helping patients obtain access to new medications. Over the last few years, the scientific rigor of this field has increased greatly. At the same time, new types of analysis, based on prospective data collection, have been developed. This article reviews the basic concept of pharmacoeconomics, the types of data available for economic evaluation, and the "state of the art" in pharmacoeconomics as reported in the medical literature.

Entities:  

Mesh:

Year:  1997        PMID: 9143730     DOI: 10.1146/annurev.publhealth.18.1.529

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  4 in total

1.  Using healthcare claims data for outcomes research and pharmacoeconomic analyses.

Authors:  H G Birnbaum; P Y Cremieux; P E Greenberg; J LeLorier; J A Ostrander; L Venditti
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

Review 2.  Cost effectiveness, quality-adjusted life-years and supportive care. Recombinant human erythropoietin as a treatment of cancer-associated anaemia.

Authors:  P Y Cremieux; S N Finkelstein; E R Berndt; J Crawford; M B Slavin
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

3.  An evaluation of the cost effectiveness of drotrecogin alfa (activated) relative to the number of organ system failures.

Authors:  Madeline Betancourt; Peggy S McKinnon; R Michael Massanari; Salmaan Kanji; David Bach; John W Devlin
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

4.  Prenatal screening for cystic fibrosis carriers: an economic evaluation.

Authors:  P T Rowley; S Loader; R M Kaplan
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.